Middle East & Africa Coagulation Market Forecast to 2030

According to the Research Team’ research, the Middle East & Africa coagulation market was valued at US$ 291.47 million in 2022 and is expected to reach US$ 467.78 million by 2030, registering a CAGR of 6.1% from 2022 to 2030. Rising prevalence of cardiovascular diseases and increasing prevalence of blood disorders are among the critical factors attributed to the Middle East & Africa coagulation market expansion.

According to the Global Hemophilia Care 2020 study, 393,658 bleeding disorders cases have been recognized and documented worldwide over time, including 241,535 hemophilia cases, 87,729 von Willebrand disease cases, and 64,394 other bleeding disorder cases. Therefore, the rising prevalence of blood disorders drives the coagulation market growth.

A coagulation analyzer is a device that measures and evaluates the speed of clot formation or clot coagulation. It provides a fast, simple way to accurately measure blood platelet levels and thrombin and thromboplastin levels. According to the Annual Global Survey 2020 conducted by the World Federation of Hemophilia, around 347,026 people had bleeding disorders, and about 209,614 people were living with hemophilia. This included 165,379 with Hemophilia A, 33,076 with Hemophilia B, 11,159 with Hemophilia type unknown, 84,197 with von Willebrand disease, and 53,215 with other bleeding disorders. Furthermore, individuals from the Middle East can also be affected by sickle cell trait. Over 100 million individuals globally possess the sickle cell trait. Sickle cell disease is one of the most common inherited blood disorders. Thus, the rising prevalence of blood disorders is driving the coagulation market.

On the contrary, high costs associated with coagulation analyzers hampers the growth Middle East & Africa coagulation market.

Based on disease indication, the Middle East & Africa coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von Willebrand’s disease, and others. The liver disease segment held 54.2% share of the Middle East & Africa coagulation market in 2022, amassing US$ 158.02 million. It is projected to garner US$ 250.26 million by 2030 to expand at 5.9% CAGR during 2022–2030.

Based on type, the Middle East & Africa coagulation market is bifurcated into clinical laboratory analyzers and point-of-care testing analyzers. The clinical laboratory analyzers segment held 66.0% share of the Middle East & Africa coagulation market in 2022, amassing US$ 192.46 million. It is projected to garner US$ 294.21 million by 2030 to expand at 5.4% CAGR during 2022–2030. Clinical laboratory analyzers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the Middle East & Africa coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held 65.1% share of the Middle East & Africa coagulation market in 2022, amassing US$ 189.83 million. It is projected to garner US$ 300.93 million by 2030 to expand at 5.9% CAGR during 2022–2030. Diagnosis is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the Middle East & Africa coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held 60.7% share of Middle East & Africa coagulation market in 2022, amassing US$ 176.97 million. It is projected to garner US$ 286.78 million by 2030 to expand at 6.2% CAGR during 2022–2030.

By end user, the Middle East & Africa coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held 60.2% share of Middle East & Africa coagulation market in 2022, amassing US$ 175.41 million. It is projected to garner US$ 285.61 million by 2030 to expand at 6.3% CAGR during 2022–2030.

Based on country, the Middle East & Africa coagulation market is categorized into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Saudi Arabia held 34.6% share of Middle East & Africa coagulation market in 2022, amassing US$ 100.73 million. It is projected to garner US$ 164.34 million by 2030 to expand at 6.3% CAGR during 2022–2030.

Key players operating in the Middle East & Africa coagulation market are Siemens Healthineers AG; ImproGen Diagnostik Kimya San & Tic Ltd Şti; Sysmex Corp; F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Transasia Bio-Medicals Ltd; and Horiba Ltd, among others.

In Feb 2021, Siemens Healthineers and Sysmex Extend Hemostasis Agreement. Siemens Healthineers and Sysmex Corporation announced the renewal of the companies’ long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis products including a multi-year extension. As part of the agreement Siemens Healthineers will distribute the new Sysmex CN Systems. In Aug 2021, Siemens Healthineers Launched Sysmex CN-3000 and CN-6000 Hemostasis Systems. This fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories.

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Coagulation Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of Blood Disorders
4.1.2 Rising Prevalence of Cardiovascular Diseases
4.2 Market Restraints
4.2.1 High Costs Associated with Coagulation Analyzers
4.3 Market Opportunities
4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
4.4 Future Trends
4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
4.5 Impact Analysis
5. Coagulation Market – Middle East & Africa Market Analysis
5.1 Middle East & Africa Coagulation Market Revenue (US$ million), 2022 – 2030
6. Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 – by Disease Indication
6.1 Overview
6.2 Middle East & Africa Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
6.3 Vitamin K Deficiency
6.3.1 Overview
6.3.2 Vitamin K Deficiency: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Liver Disease
6.4.1 Overview
6.4.2 Liver Disease: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
6.5.1 Overview
6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Development of Circulating Anticoagulant
6.6.1 Overview
6.6.2 Development of Circulating Anticoagulant: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Hemophilia
6.7.1 Overview
6.7.2 Hemophilia: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Von Willebrand’s Disease
6.8.1 Overview
6.8.2 Von Willebrand’s Disease: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Others
6.9.1 Overview
6.9.2 Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 Middle East & Africa Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Clinical Laboratory Analyzers
7.3.1 Overview
7.3.2 Clinical Laboratory Analyzers: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzers
7.4 Point-of-Care Testing Analyzers
7.4.1 Overview
7.4.2 Point-of-Care Testing Analyzers: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle east & Africa Coagulation Market – Revenue and Forecast to 2030 – by Offering
8.1 Overview
8.2 Middle East & Africa Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
8.3 Diagnosis
8.3.1 Overview
8.3.2 Diagnosis: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Middle East & Africa Coagulation Market, by Diagnosis
8.4 Treatment
8.4.1 Overview
8.4.2 Treatment: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Middle East & Africa Coagulation Market, by Treatment
9. Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 – by Technology
9.1 Overview
9.2 Middle East & Africa Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
9.3 Optical Technology
9.3.1 Overview
9.3.2 Optical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Mechanical Technology
9.4.1 Overview
9.4.2 Mechanical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Electrochemical Technology
9.5.1 Overview
9.5.2 Electrochemical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Middle East & Africa Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Clinical Laboratories
10.3.1 Overview
10.3.2 Clinical Laboratories: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals
10.4.1 Overview
10.4.2 Hospitals: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Coagulation Market – Country Analysis
11.1 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030
11.1.1.1 Middle East & Africa Coagulation Market by Country
11.1.1.2 Saudi Arabia
11.1.1.2.1 Overview
11.1.1.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.2.3 Saudi Arabia Coagulation Market, by Disease Indication
11.1.1.2.4 Saudi Arabia Coagulation Market, by Type
11.1.1.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.2.5 Saudi Arabia Coagulation Market, by Offering
11.1.1.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis
11.1.1.2.5.2 Saudi Arabia Coagulation Market, by Treatment
11.1.1.2.6 Saudi Arabia Coagulation Market, by Technology
11.1.1.2.7 Saudi Arabia Coagulation Market, by End User
11.1.1.3 South Africa
11.1.1.3.1 Overview
11.1.1.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.3.3 South Africa Coagulation Market, by Disease Indication
11.1.1.3.4 South Africa Coagulation Market, by Type
11.1.1.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.3.5 South Africa Coagulation Market, by Offering
11.1.1.3.5.1 South Africa Coagulation Market, by Diagnosis
11.1.1.3.5.2 South Africa Coagulation Market, by Treatment
11.1.1.3.6 South Africa Coagulation Market, by Technology
11.1.1.3.7 South Africa Coagulation Market, by End User
11.1.1.4 UAE
11.1.1.4.1 Overview
11.1.1.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.4.3 UAE Coagulation Market, by Disease Indication
11.1.1.4.4 UAE Coagulation Market, by Type
11.1.1.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.4.5 UAE Coagulation Market, by Offering
11.1.1.4.5.1 UAE Coagulation Market, by Diagnosis
11.1.1.4.5.2 UAE Coagulation Market, by Treatment
11.1.1.4.6 UAE Coagulation Market, by Technology
11.1.1.4.7 UAE Coagulation Market, by End User
11.1.1.5 Rest of Middle East & Africa
11.1.1.5.1 Overview
11.1.1.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication
11.1.1.5.4 Rest of Middle East & Africa Coagulation Market, by Type
11.1.1.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.5.5 Rest of Middle East & Africa Coagulation Market, by Offering
11.1.1.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis
11.1.1.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment
11.1.1.5.6 Rest of Middle East & Africa Coagulation Market, by Technology
11.1.1.5.7 Rest of Middle East & Africa Coagulation Market, by End User
12. Coagulation Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Coagulation Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Siemens Healthineers AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Şti.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sysmex Corp
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Genrui Biotech Co., Ltd.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Transasia Bio-Medicals Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Horiba Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

Table 1. Middle East & Africa Coagulation Market Segmentation
Table 2. Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 3. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 4. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 8. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 9. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 10. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 11. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 12. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 13. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 14. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 15. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 16. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 17. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 18. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 19. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 20. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 21. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 22. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 23. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 24. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 25. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 26. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 27. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 28. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 29. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 30. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 31. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 32. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 33. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 34. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 35. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 36. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 37. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 38. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 39. Recent Inorganic Growth Strategies in the Coagulation Market
Table 40. Recent Organic Growth Strategies in the Coagulation Market
Table 41. Glossary of Terms, Coagulation Market

Figure 1. Middle East & Africa Coagulation Market Segmentation, By Country
Figure 2. Middle East & Africa Coagulation Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Coagulation Market Revenue (US$ million), 2020 – 2030
Figure 5. Middle East & Africa Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 6. Vitamin K Deficiency: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liver Disease: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Development of Circulating Anticoagulant: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hemophilia: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Von Willebrand’s Disease: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Middle East & Africa Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 14. Clinical Laboratory Analyzers: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Point-of-Care Testing Analyzers: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Middle East & Africa Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 17. Diagnosis: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Treatment: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 20. Optical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mechanical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Electrochemical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Middle East & Africa Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 25. Clinical Laboratories: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Hospitals: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Coagulation Market, By Country (2022) (US$ million)
Figure 29. Middle East & Africa Coagulation Market, By Key Countries, 2022 and 2030 (%)
Figure 30. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 31. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 32. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 33. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 34. Growth Strategies in the Coagulation Market